Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
From AML to Ph.D.: How Wilmot helped one patient diagnosed with leukemia

From AML to Ph.D.: How Wilmot helped one patient diagnosed with leukemia

Ege Ozen was working toward his Ph.D. in Political Science when he was diagnosed with acute myeloid leukemia (AML). His oncology team at Wilmot and his wife have helped him through, and he achieved his goal of earning his Ph.D. in 2016. He's now a tenure-track professor at the College of Staten Island, CUNY. 

Gene Study Points Researchers toward New Pathway for Leukemia

Gene Study Points Researchers toward New Pathway for Leukemia

Leukemia is one of the hardest cancers to treat, but scientists have discovered a new, targetable pathway in one of the worst subtypes of the disease.

Teamwork toward a ‘Perfect Bullet’ for Leukemia

Teamwork toward a ‘Perfect Bullet’ for Leukemia

A trio of Wilmot investigators is developing a nanoparticle-based delivery system might be exactly the conduit that scientists have been looking for.